Cargando…
In vitro and in silico evaluations of actinomycin X(2)and actinomycin D as potent anti-tuberculosis agents
BACKGROUND: Multidrug-resistant tuberculosis (MDR-TB) is one of the world’s most devastating contagious diseases and is caused by the MDR-Mycobacterium tuberculosis (MDR-Mtb) bacteria. It is therefore essential to identify novel anti-TB drug candidates and target proteins to treat MDR-TB. Here, in v...
Autores principales: | Qureshi, Kamal Ahmad, Azam, Faizul, Fatmi, Muhammad Qaiser, Imtiaz, Mahrukh, Prajapati, Dinesh Kumar, Rai, Pankaj Kumar, Jaremko, Mariusz, Emwas, Abdul-Hamid, Elhassan, Gamal Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022501/ https://www.ncbi.nlm.nih.gov/pubmed/36935926 http://dx.doi.org/10.7717/peerj.14502 |
Ejemplares similares
-
In Vitro and In Silico Approaches for the Antileishmanial Activity Evaluations of Actinomycins Isolated from Novel Streptomyces smyrnaeus Strain UKAQ_23
por: Qureshi, Kamal A., et al.
Publicado: (2021) -
Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X(2) and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23
por: Qureshi, Kamal A., et al.
Publicado: (2021) -
In Vitro and In Silico Approaches for the Evaluation of Antimicrobial Activity, Time-Kill Kinetics, and Anti-Biofilm Potential of Thymoquinone (2-Methyl-5-propan-2-ylcyclohexa-2,5-diene-1,4-dione) against Selected Human Pathogens
por: Qureshi, Kamal A., et al.
Publicado: (2022) -
Discovery of actinomycin L, a new member of the actinomycin family of antibiotics
por: Machushynets, Nataliia V., et al.
Publicado: (2022) -
Genetic interrelations in the actinomycin biosynthetic gene clusters of Streptomyces antibioticus IMRU 3720 and Streptomyces chrysomallus ATCC11523, producers of actinomycin X and actinomycin C
por: Crnovčić, Ivana, et al.
Publicado: (2017)